Refractory Chronic Hand Eczema Responds to Oral Upadacitinib

Refractory Chronic Hand Eczema Responds to Oral Upadacitinib

Authors

  • Nada Alghamdi King Fahd University Hospital
  • Abdullah AN.Aljalfan King Fahd University Hospital
  • Abdulmajeed S. Alharbi College of Medicine, Imam Abdulrahman bin Faisal University
  • Omar I.Alrubaish College of Medicine, Imam Abdulrahman bin Faisal University
  • Serene R.Almuhaidib Dammam Medical Complex Hospital

Keywords:

Hand dermatitis, Hand Eczema, Upadacitinib, Janus kinase inhibitor.

References

Agarwal US, Besarwal RK, Gupta R, Agarwal P, Napalia S. Hand eczema. Indian J Dermatol. 2014;59(3):213-224. DOI:10.4103/0019-5154.131372. PMID: 24891648. PMCID: PMC4037938.

Thyssen JP, Schuttelaar MLA, Alfonso JH, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86(5):357-378. DOI:10.1111/cod.14035. PMID: 34971008.

Elsner P, Agner T. Hand eczema: treatment. J Eur Acad Dermatol Venereol. 2020;34 Suppl 1:13-21. DOI:10.1111/jdv.16062.

Guttman-Yassky E, Teixeira HD, Simpson EL, et al. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials [published correction appears in Lancet. 2021 Jun 5;397(10290):2150]. Lancet. 2021;397(10290):2151-2168. DOI: 10.1016/S0140-6736(21)00588-2.

Downloads

Published

2025-01-29

How to Cite

1.
Alghamdi N, AN.Aljalfan A, S. Alharbi A, I.Alrubaish O, R.Almuhaidib S. Refractory Chronic Hand Eczema Responds to Oral Upadacitinib. Dermatol Pract Concept. 2025;15(1):4685. doi:10.5826/dpc.1501a4685

Share